Sales Growth YoY (Last 12 Months): ALX Oncology Holdings (ALXO)

Public company logo of alxoncology.com (ALXO)

Oncology center capacity and plant capacity reservations are driving the growth of ALX Oncology Holdings (ALXO), as illustrated by the GURU.Markets terminal on the TTM year-over-year sales growth percentage chart. The 0.00 metric reflects current dynamics based on the production of proteins for tumor unmasking. Operational resilience is maintained through a network of external CDMO partners in California, which minimizes downtime risks.

ALX Oncology Holdings (ALXO) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 11/19/2026

ALX Oncology (ALXO) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:ALX Oncology Holdings
Product sample of alxoncology.com

For ALX Oncology Holdings (ALXO), the commercialization potential of evorpacept correlates directly with the YoY sales growth trend over the last four quarters. This metric measures the pace of revenue expansion, smoothing out short-term fluctuations via a rolling window. The calculation is based on comparing the total revenue of the current twelve months with the same period last year. A positive trend confirms business scaling; however, buying at extreme values creates the risk of overpaying for the asset.

Competitors of ALX Oncology Holdings (ALXO)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|CUE - Revenue Growth YoY (Last 12 Months)|PDSB - Sales Growth YoY (Last Twelve Months)|Annual Revenue Growth (Last Twelve Months) Sonnet BioTherapeutics Holdings SONN|MAIA: Sales Growth YoY (TTM)|LIMN - Annual Revenue Growth (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) LVTX|Sales Growth YoY (Last 12 Months) NXTC (NextCure)|Sales Growth YoY (Last Twelve Months) leaptx.com (LPTX)|INTS - Trailing Twelve Months Revenue Growth|Sales Growth YoY (TTM) SNSE (Sensei Biotherapeutics, Inc.)|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)